Login to Your Account

Other News To Note

Tuesday, September 17, 2013
Benu Biopharma, of Natick, Mass., said it has established Benu Bioventures, a biopharmaceutical investment initiative to fund and develop preclinical stage pharmaceutical investments to the human proof-of-concept stage.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription